about
Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lungTracking of magnetite labeled nanoparticles in the rat brain using MRIMultimodality PET/MRI agents targeted to activated macrophages.Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents.Antibody-functionalized magnetic polymersomes: in vivo targeting and imaging of bone metastases using high resolution MRI.The nanomedicine revolution: part 2: current and future clinical applications.Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations.Porphysome nanoparticles: Tailoring treatments with nature’s pigments
P2860
Q28390546-AE1E4DC9-BD41-4BA0-8DF0-5B48F06932A3Q28540929-2E192C77-5363-48F0-8AB0-2453F25F3780Q37625234-2A93CE41-2604-49B3-9F1A-78E5E580922FQ38046790-4E9B307E-C1A1-41F2-B6BB-B9B17DD2F707Q39162602-3A7ADB92-DA9D-4F48-855C-F8261CC71427Q39527453-DFDC638A-15DA-43B7-872D-FD0A0CC6766CQ50153603-40F0FB0B-286D-4726-9095-A7E84F129EDCQ59159030-4986B79E-484A-4457-B48D-C4D38BD181A8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanoformulations for molecular MRI.
@en
type
label
Nanoformulations for molecular MRI.
@en
prefLabel
Nanoformulations for molecular MRI.
@en
P2860
P356
P1476
Nanoformulations for molecular MRI.
@en
P2093
Angelique Y Louie
Chuqiao Tu
P2860
P304
P356
10.1002/WNAN.1170
P577
2012-04-06T00:00:00Z